Fluofarma's innovative technology brings high throughput to in vivo predictive toxicity analysis.
Our predictive technology can be used to test toxicity at an early stage in a drug's development and enables pharmaceutical companies to obtain their compounds' ecotoxicity, cytotoxicity and genotoxicity profiles using a single method.
Study of cell membrane integrity
Apoptosis
Cytolysis
Oxidative stress
Mitochondrial function
Cell proliferation…
Quantification of DNA damages
Quantification of DNA repair
Micronuclei analysis
Roche adopts Fluofarma’s platform
October 19, 2009 – Fluofarma announced today that it entered into
a multi-year agreement with Roche.
Read
More